ACCORD HEALTHCARE LIMITED
Location
Founded
2004-04-13
Risk Signals
336 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ACCORD HEALTHCARE LIMITED
Live alerts from global media, monitored by Business Radar
2024-06-14 (forbes.com)
Mortgage News: TSB, Coventry Adjust Rates
Find out what's happening with mortgage rates today and calculate monthly repayments across a range of different rates and deals. 14 June: Borrowers
Read more
2024-06-13 (forbes.com)
Mortgage News: Clydesdale Increases Rates For Low-Deposit Borrowers
Find out what's happening with mortgage rates today and calculate monthly repayments across a range of different rates and deals. 13 June: FCA Says
Read more
2024-06-06 (forbes.com)
Mortgage News: TSB, Skipton Raise Rates As Hopes Fade For June Bank Rate Cut
Find out what's happening with mortgage rates today and calculate monthly repayments across a range of different rates and deals. 6 June: Lenders Fo
Read more
2024-05-24 (forbes.com)
Mortgage News: Coventry Joins Rate-Cutters
Find out what's happening with mortgage rates today and calculate monthly repayments across a range of different rates and deals. 24 May: Society Un
Read more
2024-05-22 (forbes.com)
Mortgage News: Halifax, Santander Cut Fixed Rates In Wake Of Inflation Decrease
Find out what's happening with mortgage rates today and calculate monthly repayments across a range of different rates and deals. 22 May: More Lende
Read more
2023-02-03 (pharmiweb.com)
Takeda bolsters long-term growth with pipeline promotion and two acquisitions
Agreement announced with Nimbus Therapeutics in December to acquire potentially best-in-class TYK2 inhibitor, and with HUTCHMED in January to in-license highly selective oral tyrosine kinase inhibitor Momentum maintained with growth. .
Read more
2020-06-03 (supplychaindigital.com)
Accord Healthcare: Consistent, quality and agile supply in a crowded market
Following a major acquisition of another leading generic pharmaceutical company, Accord Healthcare looks to continue to supply the generic medicine indu...
Read more
2018-06-12 (accord-healthcare.com)
Accord Ireland is 10 | Accord Healthcare Newsroom
Accord celebrates phenomenal growth after 10 years on the Irish market since the takeover of Actavis Ireland a year ago. Tony Hynds, Accord IE MD said“ Our success as one of Ireland’ s top three generic suppliers has been down to our committed team
Read more
2017-02-21 (prnewswire.co.uk)
AMRI Announces Agreement with Accord Healthcare to Jointly Develop, Manufacture and Commercialize Parenteral Drug Products
/PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has entered into an agreement with the pharmaceutical group Ferrer and Accord Healthcare, Inc....
Read more